Literature DB >> 21098709

Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors.

Chung Kwon Kim1, Truong L X Nguyen, Kyeung Min Joo, Do-Hyun Nam, Jihye Park, Kyung-Hoon Lee, Sung-Woo Cho, Jee-Yin Ahn.   

Abstract

The ErbB3 binding protein Ebp1 has been implicated in a number of human cancers. Ebp1 includes 2 isoforms, p48 and p42, that exhibit different cellular activities. Here we show that the larger p48 isoform is transforming and that it promotes cell growth, clonogenicity, and invasion in human glioblastoma (GBM). P48 overexpression in GBM cells facilitated tumorigenesis and enhanced tumor growth in mouse xenograft models. Human GBM tissues displayed elevated levels of p48 compared with surrounding normal tissues or low-grade tumors. Notably, p48 levels were inversely correlated with poor prognosis in GBM patients. We determined that p48 binds to the p53 E3 ligase HDM2, enhancing HDM2-p53 association and thereby promoting p53 polyubiquitination and degradation to reduce steady-state p53 levels and activity. Together, our findings suggest that p48 functions as an oncogene by promoting glioma tumorigenicity via interactions with HDM2 that contribute to p53 downregulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098709     DOI: 10.1158/0008-5472.CAN-10-1882

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Roles of ErbB3-binding protein 1 (EBP1) in embryonic development and gene-silencing control.

Authors:  Hyo Rim Ko; Inwoo Hwang; Eun-Ju Jin; Taegwan Yun; Dongryeol Ryu; Jong-Sun Kang; Kye Won Park; Joo-Ho Shin; Sung-Woo Cho; Kyung-Hoon Lee; Keqiang Ye; Jee-Yin Ahn
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-20       Impact factor: 11.205

2.  ERBB3-Binding Protein 1 (EBP1) Is a Novel Developmental Pluripotency-Associated-4 (DPPA4) Cofactor in Human Pluripotent Cells.

Authors:  Priyanka Somanath; Kelly M Bush; Paul S Knoepfler
Journal:  Stem Cells       Date:  2018-01-29       Impact factor: 6.277

3.  Modulation of HCV replication and translation by ErbB3 binding protein1 isoforms.

Authors:  Priya Mishra; Updesh Dixit; Ashutosh K Pandey; Alok Upadhyay; Virendra N Pandey
Journal:  Virology       Date:  2016-10-19       Impact factor: 3.616

4.  HIV-1 viral protein R downregulates Ebp1 and stabilizes p53 in glioblastoma U87MG cells.

Authors:  S Zhang; B Zhang; X Xu; L Wang; X Feng; Q Wang; H Huang; J Wu; P Li; J Wang
Journal:  Clin Transl Oncol       Date:  2013-07-05       Impact factor: 3.405

5.  Regulation of ribosomal RNA synthesis in T cells: requirement for GTP and Ebp1.

Authors:  Le Xuan Truong Nguyen; Yunqin Lee; Lenore Urbani; Paul J Utz; Anne W Hamburger; John B Sunwoo; Beverly S Mitchell
Journal:  Blood       Date:  2015-02-17       Impact factor: 22.113

Review 6.  Using Xenopus to discover new genes involved in branchiootorenal spectrum disorders.

Authors:  Sally A Moody; Karen M Neilson; Kristy L Kenyon; Dominique Alfandari; Francesca Pignoni
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2015-06-24       Impact factor: 3.228

7.  Dysregulation of Epigenetic Control Contributes to Schizophrenia-Like Behavior in Ebp1+/- Mice.

Authors:  Inwoo Hwang; Jee-Yin Ahn
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

Review 8.  A structural view of PA2G4 isoforms with opposing functions in cancer.

Authors:  Brendan W Stevenson; Michael A Gorman; Jessica Koach; Belamy B Cheung; Glenn M Marshall; Michael W Parker; Jessica K Holien
Journal:  J Biol Chem       Date:  2020-09-20       Impact factor: 5.157

9.  Pa2G4 is a novel Six1 co-factor that is required for neural crest and otic development.

Authors:  Karen M Neilson; Genevieve Abbruzzesse; Kristy Kenyon; Vanessa Bartolo; Patrick Krohn; Dominique Alfandari; Sally A Moody
Journal:  Dev Biol       Date:  2016-12-09       Impact factor: 3.582

10.  The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.

Authors:  Baoying Hu; Yicheng Xiong; Runzhou Ni; Lixian Wei; Dawei Jiang; Gang Wang; Di Wu; Tianxin Xu; Fengbo Zhao; Mingyan Zhu; Chunhua Wan
Journal:  Mol Cell Biochem       Date:  2014-08-01       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.